Evolving Clinical Considerations for Breast Cancer Brain Metastases: Expert Case Discussions

Join us for this live, CME/ABIM MOC–certified Webinar being held during SABCS 2020, where experts Ruth O’Regan, MD, and Lee Schwartzberg, MD, FACP, will examine recent advances and current best practices in the management of brain metastases in breast cancer through discussion of patient cases.

During the live Webinar, you will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

2020 San Antonio Breast Cancer Symposium

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

Agenda

Welcome and Introduction 

Overview of Brain Metastases in Breast Cancer

Therapeutic Approaches for Brain Metastases in Breast Cancer: Current Evidence and Patient Case Discussions

  • HER2-Positive Disease
  • HER2-Negative Disease

New Therapeutic Strategies on the Horizon

Final Thoughts and Audience Question and Answer Session

Faculty

Faculty
Ruth O'Regan, MD

Professor
Division of Hematology/Oncology
Department of Medicine
UW School of Medicine and Public Health
UW Carbone Cancer Center
University of Wisconsin–Madison
Madison, Wisconsin

Faculty
Lee Schwartzberg, MD, FACP

Medical Director
West Cancer Center and Research Institute
Professor of Medicine
University of Tennessee
Health Science Center
Memphis, Tennessee

Goal Statement
The goal of this activity is to improve the competence and performance of learners to apply practice-changing clinical data and expert recommendations regarding the treatment of patients with metastatic breast cancer and CNS metastases.

Target Audience
This program is intended for oncologists and other clinicians involved in the management of metastatic breast cancer patients with CNS metastases.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the risk factors associated with CNS metastases in patients with breast cancer
  • Evaluate available and emerging clinical data on the use of systemic therapies to treat breast cancer brain metastases
  • Incorporate expert consensus and guideline recommendations into practice taking a multidisciplinary team approach to treatment
  • Integrate new therapeutic approaches into clinical practice for patients with brain metastases from breast cancer based on individual patient and tumor characteristics

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification
Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.